{"id":67055,"name":"KYOWA KIRIN, INC","slug":"kyowa-kirin-inc","state":"NJ","country":"United States of America","description":"Pharmaceutical company","totalSpending":460000,"filings":4,"yearlySpending":[{"year":2025,"income":460000}],"issues":["PHA","TRD"],"firms":["KYOWA KIRIN, INC"],"lobbyists":["EDWARD BUCKLEY"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Commerce, Dept of (DOC)","Treasury, Dept of","U.S. Trade Representative (USTR)"],"sampleDescriptions":["FDA modernization policy issues General issues related to rare disease and clinical trials General issues related to diagnostics for patients with rare diseases Issues related to drug pricing Issues r","FDA modernization policy issues. General issues related to rare disease and clinical trials. General issues related to diagnostics for patients with rare diseases. Issues related to drug pricing. Issu","Issues related to trade.","Trade/tariffs and pharmaceutical pricing/value","Tariffs and trade policy"],"years":[2025]}